SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 133 filers reported holding SYNAGEVA BIOPHARMA CORP in Q1 2015. The put-call ratio across all filers is 3.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $568,000 | -37.0% | 5,825 | -40.1% | 0.01% | -33.3% |
| Q4 2014 | $902,000 | +25.5% | 9,725 | -7.0% | 0.02% | +15.4% |
| Q3 2014 | $719,000 | -56.5% | 10,455 | -33.6% | 0.01% | -53.6% |
| Q2 2014 | $1,651,000 | +26.3% | 15,755 | 0.0% | 0.03% | +21.7% |
| Q1 2014 | $1,307,000 | – | 15,755 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|